
The zzso of acute zzso leukemia zzso increases with zzso Older zzso patients, generally defined by age zzso or zzso 60 years, have worse treatment outcomes than younger zzso While selected older patients can benefit from standard therapies, as a group they experience greater zzso zzso lower zzso rates, shorter zzso survival times, and shorter overall survival zzso zzso disparity is in part explained by age-related zzso zzso Older patients are more likely to present with zzso zzso zzso zzso resistance zzso and secondary zzso However, even older adults with favorable tumor biology have a worse prognosis than younger zzso zzso factors, including impaired physical function and zzso independently predict greater treatment toxicity and shorter zzso zzso patient assessment strategies is critical to identify those patients who are most likely to benefit from induction and zzso zzso In addition, continued efforts to identify more effective and tolerable induction and zzso strategies are needed for this zzso zzso of zzso agents and signal zzso zzso hold promise for the treatment of zzso zzso Steady advances in the field of zzso zzso including use of reduced intensity transplants, may result in additional zzso options available to selected older zzso Finally, improved supportive care strategies are needed to maximize treatment zzso 

